704-1332

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-12-09

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild BURNING SENSATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-03 (study day 57.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-18 (study day 41.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-01-18 (study day 41.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-10 (study day 2.0); relationship: NONE

moderate assessed

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-10 (study day 2.0); relationship: NONE

moderate assessed

Moderate RASH — outcome: RECOVERED/RESOLVED; onset 2013-12-10 (study day 2.0); relationship: NONE

Data queries

No data queries.